skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

もっと見る

Resources

もっと見る

もっと見る

Products

もっと見る

もっと見る

8 Total results for product and free and sample content found

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

The Times They Are A-Changin’: Opportunities In Medtech Regulation For The UK After Brexit

27 Jan 2021

The turn of the year is a chance to reflect on times past and the future, to make resolutions and look ahead to changes for the better. With Brexit in mind, this is the time to prophesize on UK medtech’s immediate future.

Topic Regulation Market Access Medtech-Brexit

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

From US To EU: Young Biotechs Going It Alone

27 Nov 2020

Europe’s patchwork of reimbursement agencies make it a daunting place for a small US biotech to do business. Traditionally large pharma partners or CMSOs have provided an experienced hand to hold, but as a new wave of gene therapies and orphan drugs get the EMA green light, smaller drug developers are applying innovation to commercialization and choosing to go solo.

Topic Market Access Rare Diseases Strategy

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

'We Cannot Afford To Be An Island': Bayer's UK CEO Shares Anti-Brexit Opinion

25 Aug 2020

In the lead up to the June 23 referendum to decide whether Britain should leave or remain in the European Union, Dr. Alexander Moscho, CEO of Bayer UK & Ireland, shares his opinion on how leaving the EU could be a setback for life sciences and impact patients significantly in regard to access to medicines.

Topic brexit Market Access

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

The Sensational Trumps Sense As UK Voters Show Appetite For "Brexit"

25 Aug 2020

As night turned to day on June 24, it became clearer by the hour that the unthinkable had happened, and the UK’s long and acrimonious debate about its 43-year membership of the European Union had ended in a victory for the Leave group. The local health care products industries made their views clear some weeks ago, but today and in the months to come, they will have to confront a Plan B that was never in the plans.

Topic Market Access Brexit

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

2020 Titans Of Pharma Infographic

06 Jul 2020

Scrip’s eagerly awaited annual snapshot of pharma leadership in 2020 is here. The 2020 Titans of Pharma infographic features key information on the industry’s top leaders and the mega companies they oversee.

Topic Leadership Market Access

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Titans of Pharma 2020: A Bumper Year For Top Executive Compensation

06 Jul 2020

CEO pay at the top 15 pharma companies increased by 3.9% in 2019. But how did that match up to company performance? Read the article now available from Scrip and learn who were the big winners, and how their companies performed financially.

Topic Leadership company-analysis Market Access

The Changing Landscape of Pharma Marketing

30 Apr 2020

The Changing Landscape of Pharma Marketing

Understanding the intricacies of pharma marketing can be tough, but Skipta has you covered. A leading social network of specialized online medical communities for over 700,000 verified healthcare professionals, Skipta can pinpoint and connect you to your exact targets – quickly and easily.

Topic Market Access

Pharma Marketing 2020: Maximising product launch success amid complex legislative change

30 Mar 2020

Pharma Marketing 2020: Maximising product launch success amid complex legislative change

Healthcare professionals are notoriously hard to reach with new product messaging. Skipta makes it easier. A social network for verified physicians, Skipta communities are segmented by area of expertise or disease state. Use Skipta to create custom, targeted campaigns to reach your audience when they’re most ready to engage.

Topic Market Access

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問い合わせの際は下記のフォームまたはメールアドレスをご利用下さい。

Eメール:inquiry.jp@informa.com


オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。